Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polydioxanone (PDO) is a synthetic, biodegradable, monofilament polymer used extensively in medical applications, particularly as an absorbable surgical suture and in aesthetic medicine as a facial implant thread. Developed and marketed by companies such as IMEIK Technology Development, PDO threads are utilized for facial tissue lifting and aesthetic repair. The polymer is broken down in the body via hydrolysis into glyoxylate and ethoxyacetic acid, which are subsequently excreted. In aesthetic procedures, the insertion of PDO threads into the subdermal tissue provides an immediate mechanical lift to sagging skin and triggers a long-term foreign body response that stimulates the production of new collagen (neocollagenesis). This process enhances skin elasticity and structural integrity even after the thread has been fully absorbed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polydioxanone (IMEIK Technology Development).